These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 32507936)

  • 1. Chemoprevention in familial adenomatous polyposis: past, present and future.
    Kemp Bohan PM; Mankaney G; Vreeland TJ; Chick RC; Hale DF; Cindass JL; Hickerson AT; Ensley DC; Sohn V; Clifton GT; Peoples GE; Burke CA
    Fam Cancer; 2021 Jan; 20(1):23-33. PubMed ID: 32507936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemoprevention with special reference to inherited colorectal cancer.
    Lynch PM
    Fam Cancer; 2008; 7(1):59-64. PubMed ID: 17680350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoprevention of familial adenomatous polyposis.
    Lynch PM
    Fam Cancer; 2016 Jul; 15(3):467-75. PubMed ID: 27083160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
    Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
    BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
    Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
    Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Updated Perspectives on the Diagnosis and Management of Familial Adenomatous Polyposis.
    Kyriakidis F; Kogias D; Venou TM; Karlafti E; Paramythiotis D
    Appl Clin Genet; 2023; 16():139-153. PubMed ID: 37600856
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemoprevention with low-dose aspirin, mesalazine, or both in patients with familial adenomatous polyposis without previous colectomy (J-FAPP Study IV): a multicentre, double-blind, randomised, two-by-two factorial design trial.
    Ishikawa H; Mutoh M; Sato Y; Doyama H; Tajika M; Tanaka S; Horimatsu T; Takeuchi Y; Kashida H; Tashiro J; Ezoe Y; Nakajima T; Ikematsu H; Hori S; Suzuki S; Otani T; Takayama T; Ohda Y; Mure K; Wakabayashi K; Sakai T
    Lancet Gastroenterol Hepatol; 2021 Jun; 6(6):474-481. PubMed ID: 33812492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemoprevention in familial adenomatous polyposis.
    Kim B; Giardiello FM
    Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):607-22. PubMed ID: 22122775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemoprevention for Familial Adenomatous Polyposis].
    Matsubara N; Tamura K; Tomita N
    Gan To Kagaku Ryoho; 2015 Jun; 42(6):699-703. PubMed ID: 26199240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoprevention of colorectal neoplasia.
    Wakeman C; Keenan J; Eteuati J; Hollington P; Eglinton T; Frizelle F
    ANZ J Surg; 2017 Dec; 87(12):E228-E232. PubMed ID: 26686322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemoprevention of intestinal carcinogenesis in a murine model of familial adenomatous polyposis.
    Ignatenko NA; Besselsen DG; Stringer DE; Blohm-Mangone KA; Cui H; Gerner EW
    Nutr Cancer; 2008; 60 Suppl 1():30-5. PubMed ID: 19003578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin and familial adenomatous polyposis: coming full circle.
    Chan AT
    Cancer Prev Res (Phila); 2011 May; 4(5):623-7. PubMed ID: 21543340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colorectal cancer chemoprevention: is this the future of colorectal cancer prevention?
    Manzano A; PĂ©rez-Segura P
    ScientificWorldJournal; 2012; 2012():327341. PubMed ID: 22649288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Familial adenomatous polyposis (FAP)--diagnosis and management].
    Gondo N; Nakagawa K; Yanagi H; Yamamura T
    Gan To Kagaku Ryoho; 2002 Apr; 29(4):532-8. PubMed ID: 11977536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoprevention of carcinogenesis in familial tumors.
    Ishikawa H
    Int J Clin Oncol; 2004 Aug; 9(4):299-303. PubMed ID: 15375706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoscopic and chemopreventive management of familial adenomatous polyposis syndrome.
    Stone JK; Mehta NA; Singh H; El-Matary W; Bernstein CN
    Fam Cancer; 2023 Oct; 22(4):413-422. PubMed ID: 37119510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial adenomatous polyposis.
    Half E; Bercovich D; Rozen P
    Orphanet J Rare Dis; 2009 Oct; 4():22. PubMed ID: 19822006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of Sulindac and Bexarotene for Prevention of Intestinal Carcinogenesis in Familial Adenomatous Polyposis.
    Bowen CM; Walter L; Borras E; Wu W; Ozcan Z; Chang K; Bommi PV; Taggart MW; Thirumurthi S; Lynch PM; Reyes-Uribe L; Scheet PA; Sinha KM; Vilar E
    Cancer Prev Res (Phila); 2021 Sep; 14(9):851-862. PubMed ID: 34266857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib: new indication. Colorectal cancer: no preventive benefit.
    Prescrire Int; 2006 Feb; 15(81):13-5. PubMed ID: 16548099
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.